T-Cell Receptor Gene Therapy for Human Papillomavirus–Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
Stacey L. Doran(National Institutes of Health), Christian S. Hinrichs(National Institutes of Health)
Cited by 259
Related Papers
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy
|Blood|2008|459
Enhanced efficacy and limited systemic cytokine exposure with membrane-anchored interleukin-12 T-cell therapy in murine tumor models
|Journal for ImmunoTherapy of Cancer|2020|51
Non-synergy of PD-1 blockade with T-cell therapy in solid tumors
|Journal for ImmunoTherapy of Cancer|2022|17